Page last updated: 2024-12-10

sarcophytol a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sarcophytol A: structure given in first source; isolated from a soft coral Sarcophyton glaucum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Sarcophytongenus[no description available]OrchidaceaeA plant family of the order Asparagales. All members of the orchid family have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.[MeSH]

Cross-References

ID SourceID
PubMed CID5284454
CHEMBL ID462849
CHEBI ID182105
SCHEMBL ID15071367
MeSH IDM0163745

Synonyms (21)

Synonym
CHEBI:182105
(1s,2z,4e,8e,12e)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol
72629-69-7
(1s,2z,8e,12e)-5,9,13-trimethyl-2-(1-methylethyl)cyclotetradeca-2,4,8,12-tetraen-1-ol
ccris 3343
2,4,8,12-cyclotetradecatetraen-1-ol, 5,9,13-trimethyl-2-(1-methylethyl)-, (s-(z,e,e,e))-
2,4,8,12-cyclotetradecatetraen-1-ol, 5,9,13-trimethyl-2-(1-methylethyl)-, (1s,2z,4e,8e,12e)-
sarcophytol a
(1s,2z,4e,8e,12e)-2-isopropyl-5,9,13-trimethyl-cyclotetradeca-2,4,8,12-tetraen-1-ol
sarcophytol-a
CHEMBL462849
(s)-sarcophytol a
240025685w ,
(+)-sarcophytol a
unii-240025685w
sarcophytol a, (+)
YADVRLOQIWILGX-MIWLTHJTSA-N
SCHEMBL15071367
DTXSID5021257
(s,2z,4e,8e,12e)-2-isopropyl-5,9,13-trimethylcyclotetradeca-2,4,8,12-tetraen-1-ol
Q27253783
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cembrane diterpenoidOne of a class of 14-membered macrocyclic diterpenoids characterised by the presence of an isopropyl group at C-1 and by three symmetrically disposed methyl groups at C-4, -8 and -12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID356938Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 1000 molar ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID1762743Antiinflammatory activity against mouse BV2 cells assessed as reduction in LPS-induced IL-1beta mRNA expression incubated for 2 hrs followed by LPS stimulation and measured after 6 hrs by qRT-PCR analysis2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Ximaoglaucumins A - F, new cembranoids with anti-inflammatory activities from the South China Sea soft coral Sarcophyton glaucum.
AID356940Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 100 molar ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID356945Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID1762746Cytotoxicity against mouse BV2 cells assessed as cell viability at 10 uM measured after 24 hrs by MTT assay2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Ximaoglaucumins A - F, new cembranoids with anti-inflammatory activities from the South China Sea soft coral Sarcophyton glaucum.
AID1762747Antiinflammatory activity against mouse BV2 cells assessed as reduction in LPS-induced IL-6 mRNA expression incubated for 2 hrs followed by LPS stimulation and measured after 6 hrs by qRT-PCR analysis2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Ximaoglaucumins A - F, new cembranoids with anti-inflammatory activities from the South China Sea soft coral Sarcophyton glaucum.
AID356943Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID356939Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 500 molar ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID356941Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 10 molar ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID356944Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID356942Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio2002Journal of natural products, Dec, Volume: 65, Issue:12
Semisynthesis of new sarcophine derivatives with chemopreventive activity.
AID1762744Antiinflammatory activity against mouse BV2 cells assessed as reduction in LPS-induced NO production at 10 uM incubated for 2 hrs followed by LPS stimulation and measured after 24 hrs by Griess reagent based assay relative to control2021Bioorganic & medicinal chemistry, 05-15, Volume: 38Ximaoglaucumins A - F, new cembranoids with anti-inflammatory activities from the South China Sea soft coral Sarcophyton glaucum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's17 (65.38)18.2507
2000's5 (19.23)29.6817
2010's0 (0.00)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.67 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (11.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (88.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]